Montréal, QC H4S 1Z9 Canada
+1 (438) 923 9257
Christophe Brun-Baronnat, MSc, is the Senior Researcher at the CERASP. After obtaining his biochemist degrees, he obtained his master’s degree in Production Processes, Quality and Control of Health Products at the University of Pharmaceutical Sciences of Toulouse / ENCIACET (National School of Engineers in Chemical and Technological Arts of Toulouse – France). Since 1991, he has held various positions: in formulation, in process development, in technology transfer, in project management CDMOs and as R&D unit Director at PFIZER France. He has over 30 years of experience in the field of GMP / GLP in the pharmaceutical and biotechnology / food processing industries and has extensive experience in formulation of pharmaceutical forms, biotechnology and pharmaceutical processes. His knowledges into multiple sciences gave him the opportunity to work in various fields such as: formulation, pharmaceutical processes, food and biotechnology, animal and plant cell cultures, genetics and biomolecular engineering, enzymatic biocatalysis, fermentation and development analytic. He has worked for a big food processing / agribusiness group, for small companies, for CDMOs, for big pharmas, with EMA (European Medicine Agency) and has produced therapeutic units for various drugs for clinical trials. Throughout his professional career, he has supervised numerous of french and foreign students of various levels and scientific specialties, many of them during the ERASMUS program.
He has also some patents in the field of drug delivery. One of his greatest successes is the development of an anti-cancer drug for young children. All fields combined, there are many products he has developed that are on the market today. Recently, he formulated and obtained licenses from Health Canada for a hydro-alcoholic gel (PURIFAB, NPN 80098706) and hydro-alcoholic solutions (NPN80098806, NPN80098754, NPN80098706) for the fight against COVID-19.
Christina Aon is pharmaceutical professional with extensive international experience garnered developing strategy, leading and implementing large-scale pharmaceutical projects such as facilitating the successful merger of GSK Vaccines Japan and Daiichi Sankyo, prioritizing key activity transfers on three continents. She has over 20 years of international pharmaceutical experience spanning three continents for GSK Pharma, GSK Vaccines and Abbott Laboratories. She has held positions in Commercial Sales and Marketing, Supply Chain, GMP Manufacturing and Compliance, Business Excellence (OE Lean SixSigma) and Performance Management and Strategy setting and her last role was as Global Development & Learning Director for GSK. She has proven expertise in the areas of cross-cultural learning and development to meet organizational needs and manage skill gaps via competency models, manufacturing process improvement focused on quality, cost and productivity as well as sales, marketing and logistics experience. She holds her BSc. From McGill University in Montreal, Canada, her Six Sigma GreenBelt from the University of St-Louis, in Missouri, USA and an International Executive MBA from the Louvain School of Management in Belgium.
Rosanne Séguin, Ph.D., is the scientific grant writer at the CERASP. Dr. Séguin received her Ph.D. from McGill University and did post-doctoral fellowships at Dartmouth College in New Hampshire and the Montreal Neurological Institute. She worked in the Montreal biotechnology sector for over a decade, in the discovery and development of cell therapies and antisense oligonucleotides before returning to academia. At the Montreal Neurological Institute she coordinated pharmaceutical company sponsored clinical studies, managed investigator-initiated clinical studies and obtained funding support for the latter studies through non-profit and governmental grants. At the CERASP, she has undertaken writing scientific grants for industrial partners and collaborations with other academic institutions. Her research for 25 years has covered the fields of infectious diseases, immunology, respiratory disease, autoimmunity, and neurological diseases.